Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT07781800
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Breast Cancer
- Cancer of Breast
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Patient navigator — BEHAVIORALPatient navigator will contact the patient every 3 weeks to check in, assess if patient requires additional resources, connect patient to existing nonprofit and local resources, remind patient of appointments, and ask about barriers to clinic visits.
Study Details
This study aims to assess how individual patient social stressors are associated with barriers to care by analyzing a patient navigator system. Patient navigators will connect patients with unmet social needs with community resources.
Key Dates
- First listed
- Aug 24, 2026
- Start date
- Sep 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 180 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Patient navigation interventionPatients will be connected with a patient navigator following consent. The navigator will ask the patient questions regarding social determinants of health risks including transportation difficulties, financial stability, and housing stability. Patient will receive full social determinants of health (SDOH) screening via iPad at initial consult visit. Based on SDOH screening, if the patient is high risk the patient will be referred to appropriate resources.
Primary Outcome Measure
Percentage of patients with chemotherapy deferrals [ Time Frame: 6 months ]
Central Contacts
- Emily L Podany, MD, MPHS314-273-4474
- Katherine N Weilbaecher, MD314-362-5654
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63310 | Emily L Podany, MD, MPHS (PRINCIPAL_INVESTIGATOR) Benjamin Bowe, PhD (SUB_INVESTIGATOR) Andrew Davis, MD (SUB_INVESTIGATOR) Faisal Fa'ak, MD (SUB_INVESTIGATOR) Cynthia X Ma, MD, PhD (SUB_INVESTIGATOR) Katherine N Weilbaecher, MD (SUB_INVESTIGATOR) |
Find similar trials in St Louis, MO
By condition
By specialty
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier RegistryRecruiting · University of Kansas Medical Center · Hays, Kansas
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScorePHASE2 · Recruiting · Washington University School of Medicine · St Louis, Missouri
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Anchorage, Alaska